Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Exposure order blocks unfamiliar immune cells through receptor-specific inhibitory signals

Familiar can activate while inhibiting unfamiliar . The hypothesis predicts that changing those to avoid will remove the in lasting unfamiliar-cell descendants.

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Biological function

T-cell receptors discriminate among peptides presented by major histocompatibility complex molecules, producing activating, nonproductive or inhibitory signals depending on the receptor–ligand pairing. This discrimination regulates initial T-cell activation and the establishment of persistent clonal descendants.T-cell antigen discrimination

Direction

Lens

Puts the cause in what the system senses and how that signal is held and passed on, rather than in what it is made of.Information and sensing

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Goal
Repertoire Renewal–Retention Competition and Selectivity Failure Resistance
Competing hypotheses
2
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
8 / 10Clarity of mechanism
6 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Signalling pathway

    -receptor signaling

    Signaling through receptors during cognate recognition

    Where this hypothesis actsUnfamiliar T cells during their in the presence of familiar

    Hypotheses on this target 4
    Antigen-receptor signalingInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 11
    • Inhibition1
    • Activation
    • Desensitisation
    • Function preservation
    • Feedback restoration
    • Rhythm restoration1

    What is proposed

    Inhibition

    Suppress antagonistic signaling while preserving productive recall stimulation

    With whatProtein or peptide as the agent

    HowSubstitute familiar with variants outside the unfamiliar 's mapped while retaining equivalent recall stimulation

    Possible result

    Possible abolition of the order-dependent persistence deficit in unfamiliar T-cell

    From the recordfamiliar peptide variants that retain equivalent recall stimulation but move outside the unfamiliar TCR's independently mapped antagonist region will abolish the order-dependent persistence deficit.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signaling
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Restoring an aging immune system means gaining new protection while keeping protection already learned. The unexpected move is that familiar targets might actively obstruct new responses through the very receptors that recognize threats, even when resources are unchanged. This is a proposal generated by the pipeline, not a measured explanation of immune aging.

The proposed mechanism, link by link
  1. Exposure order changes which familiar target fragments unfamiliar receptors encounter during their first activation period.
  2. The same familiar fragments are proposed to activate established responses while inhibiting particular unfamiliar receptors.
  3. Familiar-first exposure leaves inhibitory targets present while unfamiliar , the first cells attempting to establish a new response, begin activation.
  4. Unfamiliar-first exposure permits commitment to a lasting response; familiar-first exposure blocks that commitment in susceptible .
  5. Blocked fail to establish lasting descendants, making persistence depend on which targets inhibit their receptors rather than on the amount of shared resources.
A picture for it

A message that means “go” to one recipient can mean “stop” to another. If the stop message arrives before a new activity gets started, its timing can decide whether that activity ever takes hold.

Where the picture breaks: Immune receptors respond through physical interactions and cellular signaling, not interpretation. The picture does not establish that the same familiar target has opposite effects on the relevant receptors or that those effects prevent lasting descendants.

  1. Master questionstep 01 of 04

    People with age-related immune decline need lasting recovery of both , the body's broadly acting defenses, and , its defenses directed at particular targets. The goal requires function within healthy young-adult ranges while preserving , protection learned from earlier encounters; , restraint against attacking the body's own tissues; and control of , infections that persist without continuous active disease.

    Rests on: The stated goal defines success as restored function together with preservation of existing protection and restraint.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Renewing the , the collection of distinct targets immune cells can recognize, must coexist with retaining established responses and resisting failures of target discrimination.

    Rests on: The master question requires new function without losing existing protection. The pillar frames renewal and retention as competing demands.

    Assumption

    Competition between renewal and retention is taken as the organizing problem; the master question requires both outcomes but does not establish that they compete.

  3. Gap questionstep 03 of 04

    The order of encounters with immune targets might decide whether , groups of immune cells sharing a target-recognition identity, persist despite equal total target exposure, sleep loss, and nutrient availability. Persistence is framed using a , a boundary in a population-interaction model between a rare population establishing itself and failing to establish.

    Rests on: The pillar names competition between renewal and retention, but supplies no account connecting that competition to exposure order or this population model.

    Leap

    The supplied chain lacks a bridge from renewal–retention competition to an exposure-order effect governed by a .

  4. Hypothesisstep 04 of 04

    Familiar target fragments are proposed to stimulate established responses while inhibiting some unfamiliar , the recognition proteins through which these immune cells detect displayed targets. Familiar-first exposure would interrupt the first activation period needed to establish lasting descendants; unfamiliar-first exposure would allow that process to begin before inhibition arrives. The apparent persistence boundary would therefore depend on target discrimination rather than shared resource capacity.

    Rests on: The preceding question supplies the proposed exposure-order difference under matched resources. The hypothesis supplies an explicit candidate explanation and borrows a geometric model that groups receptors by measured responses to targets; its regions of inhibition are proposed approximations requiring independent validation.

    Stated in the chain

What is carried, and what is not. Of the five mechanism links listed here, screened sources speak directly to a component of one: target-dependent receptor inhibition. S1, available only as an abstract from Nature in 1996, reports that target variants involved in selection of developing immune cells can inhibit mature , and S2, in Frontiers in Molecular Biosciences in 2015, analyzes activating and inhibitory target variants bound to one human receptor; neither establishes the proposed familiar-versus-unfamiliar pairing, exposure-order effect, or sequence leading to failed lasting establishment.S1S2

Where the reasoning is carried by something unstated · 2
  • Goal pillar. Competition between renewal and retention is taken as the organizing problem; the master question requires both outcomes but does not establish that they compete.
  • Gap question. The supplied chain lacks a bridge from renewal–retention competition to an exposure-order effect governed by a . Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A changed target could remove the persistence deficit by changing how much target is displayed, rather than by removing receptor inhibition. Equivalent stimulation of established responses alone would not separate those explanations. What closes it: The proposed standardized , display of target fragments bound to cell-surface recognition platforms, must establish comparable display across variants. The design also requires fixed unfamiliar activating-target , , additional activation-supporting signals, and , signals exchanged between cells.
  • An early activation change could be read as of lasting establishment, or disappearance of could be credited to receptor inhibition when killing or chance loss caused it. What closes it: The specified follow-up through target withdrawal and , renewed exposure to the target, is required to establish persistence. Distinguishing the rivals also requires tracking activation, division, death, and surviving descendants; the proposed test without established-response , immune cells including those capable of killing targets, must establish which of these events receptor inhibition reproduces.
  • Regions drawn around receptors already known to fail could appear predictive even if the proposed geometric organization is wrong. What closes it: The , a map placing receptors according to independently measured target responses, must be constructed independently of the persistence outcomes being predicted. Its proposed shell-shaped inhibitory regions and exposure-duration threshold must be calibrated separately, then tested on , receptors whose outcomes were not used to fit the model; no numerical threshold is supplied.

What would make this wrong. The central explanation would fail if familiar targets independently verified to no longer inhibit the unfamiliar receptors left the exposure-order persistence deficit intact, despite matched target display, unfamiliar activation signals, and established-response stimulation. failing to predict susceptible would specifically reject the geometric model, without by itself excluding every possible receptor-inhibition mechanism.

What it would change. If the hypothesis held, preserving established immune responses during renewal would require accounting for whether their familiar targets inhibit incoming cells during initial activation, alongside resource availability. The master question would therefore include compatibility between retained targets and new receptors as a candidate condition for successful renewal. Even then, the supplied work would not establish durable restoration across both broad and target-specific defenses in aging people, preservation of , or continued control of . The claimed stabilization target, , is not defined in the supplied material, so its contribution to those goals cannot be specified.

Sources read · 8

3 literature searches, 9 full texts, 1 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1BackgroundAbstract only

T-cell-receptor affinity and thymocyte positive selection. · Nature · 1996

“Antigen analogues, and sometimes low concentrations of antigenic peptide, induce positive selection; such analogues are often antagonists of mature T-cell clones.”

Does not settle: This source does not establish exposure-order effects, founding activation windows, recall versus unfamiliar receptors, durable descendants, population invasion thresholds, receptor-specific exclusion regions, or SPV_7 stability.

S2Partly answers it

Atomic Coordination Reflects Peptide Immunogenicity. · Frontiers in molecular biosciences · 2015

“The antigens used were the cognate HTLV-1 Tax peptide (LLFGYPVYV, PDB entry 1AO7) (index peptide), the weak agonist (or null peptide) V7R (LLFGYPRYV, PDB entry 1QSE), the weak antagonist Y8A (LLFGYPVAV, Protein data bank—PDB entry 1QSF) and the antagonist P6A (LLFGYAVYV, PDB entry 1QRN).”

Does not settle: This source does not establish that exposure order changes founding activation, excludes unfamiliar TCRs, creates durable descendants, or defines a population invasion threshold. It analyzes variants bound to one human A6TCR and does not test sequential exposure or SPV_7.

S3Background

Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination. · PLoS pathogens · 2020

“The TCR P14 is specific for H-2D b /gp33 and it has been previously demonstrated that P14 recognition is abolished by the Y4F mutation [ , ].”

Does not settle: This source does not establish effects of exposure order, antagonistic or inhibitory signaling through unfamiliar TCRs, exclusion regions in recognition space, founder-cell commitment, durable descendants, population invasion thresholds, or reducing antagonist overlap for SPV_7.

S4Background

T cell costimulatory and inhibitory signals differentially modulate LAT condensate nucleation propensity after TCR ligation. · bioRxiv : the preprint server for biology · 2025

“Here we characterize how the LAT condensation process is modulated by CD28 costimulatory or PD-1 inhibitory signals.”

Does not settle: This source does not establish exposure-order effects, antagonistic familiar peptide–MHC ligands acting through unfamiliar TCRs, founder-cell exclusion, durable descendants, recognition-space boundaries, or SPV_7 stabilization.

S7Background

IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation. · PloS one · 2016

“In MS, it is currently unknown whether an aberrant Th cell reactivity is always directed against the same antigen, or whether these responses diversify during sequential clinical attacks or disease progression.”

Does not settle: It does not establish how antigen exposure order affects founding T-cell activation, whether familiar peptide–MHC ligands inhibit unfamiliar TCRs, receptor-specific exclusion regions, durable descendant formation, or SPV_7 stabilization.

S8Background

Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination. · Journal of immunology (Baltimore, Md. : 1950) · 2004

“The efficiency of T cell-priming in vivo by transferred DCs should depend on their encounter with T cells.”

Does not settle: This source does not test exposure order, antagonistic familiar peptide–MHC ligands, inhibitory signaling through unfamiliar TCRs, receptor-specific exclusion, founder activation or durable descendants, recognition-discrimination boundaries, or SPV_7.

S9Background

Molecular mechanisms of T cell co-stimulation and co-inhibition. · Nature reviews. Immunology · 2013

“Together, these studies indicate that co-inhibitory receptors use related yet distinct signalling pathways to regulate T cells.”

Does not settle: This source text does not establish effects of exposure order, familiar peptide–MHC antagonism of unfamiliar TCRs, founder-cell exclusion, durable descendants, population invasion thresholds, or stabilization of SPV_7.

S10Partly answers it

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. · The Journal of experimental medicine · 2000

“These results show that PD-L1 can attenuate TCR-mediated T cell proliferation. Furthermore, the failure of PD-L1 to inhibit PD-1 –deficient T cells indicates that PD-L1 conveys this signal via its interaction with PD-1.”

Does not settle: This source does not test peptide–MHC antagonist overlap, exposure order, unfamiliar versus recall TCRs, founding activation windows, durable descendants, population invasion thresholds, or SPV_7.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Can changing exposure order make immune-cell families targeting unfamiliar threats persist or disappear despite identical total exposures and resources?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Does exposure order switch persistence across a even when total , sleep loss, and nutrient availability are identical?

What this question is asking

The question concerns whether the sequence of exposures changes which families of immune cells remain available to recognize unfamiliar threats. It asks whether changing that sequence, while holding the total amount of , sleep loss, and nutrient availability identical, changes whether those families persist. It frames that change as crossing a , assuming that a mathematical boundary between successful establishment and failure describes this immune system. The larger distinction is between a temporary redistribution of immune responses and permanent loss of the ability to recognize particular threats. The stated requirement also includes recovery into predefined ranges between repeated cycles, without accumulating deficits or progressively slower recovery over ten years.

What the terms mean
Exposure order
The sequence in which exposures occur. The question changes this sequence while requiring the specified totals and resource conditions to remain identical.
Antigen
A substance or molecular feature recognized by the immune system. Matching total means matching its overall amount, although the supplied material does not specify how amounts from different exposures are compared.
Immune-cell clone or clonotype
A family of immune cells grouped by shared ancestry or recognition identity. In this question, persistence of such a family is distinct from the size of its response at one measurement.
Unfamiliar clone
The question's label for an immune-cell family associated with an unfamiliar target. The supplied material does not define what makes a target unfamiliar or how that label is assigned to a family.
Specificity or recognition ability
The particular target or targets an immune response can recognize. Loss of one cell family and loss of a recognition ability are separate claims; the supplied material does not establish their equivalence.
Persistence
Continued presence of a cell family over time. The supplied material does not give the duration, minimum abundance, or measurement needed to count a family as persisting.
Lotka–Volterra model
A class of mathematical models describing how interacting populations change in size. Its use here is a proposed way to describe competition among immune-cell families, rather than evidence that a particular biological threshold exists.
Invasion threshold
A model boundary separating conditions in which a rare population can initially increase from conditions in which it cannot. Initial increase alone does not establish long-term persistence or irreversible loss.
Calibrated threshold
A proposed boundary whose parameters have been tied to measurements in the relevant system. No numerical or measured boundary for this question is supplied.
T cell
A type of immune cell involved in recognizing targets and coordinating or carrying out immune responses. S1 models competition among families of these cells sharing stimuli.
Stimuli
Signals or inputs that influence cells. S1 says the modeled T-cell families share stimuli, but the supplied quotation does not specify those inputs.
Antigenic competition
Interaction between responses to different , such that one response can affect another. The term alone does not establish that exposure order causes lasting loss of an immune-cell family.
Antibody-producing cells
Immune cells that release proteins able to bind particular targets. S9 measures cells whose antibody activity is associated with destruction of red blood cells in the study's test.
Nude mice
Mice with impaired T-cell development, used in the comparison reported by S9. They are a particular animal model, not a direct representation of age-related in people.
Inbred guinea-pig strain
A guinea-pig breeding line with a closely shared genetic background. S10 identifies strain 2 as its experimental animal population.
Immune surveillance
Immune-system activity that recognizes and acts against abnormal cells. S2 places competition among cancer-cell families in this setting.
Liver colonization
The ability of cancer cells to establish themselves in the liver. This is the outcome described in S2, distinct from persistence of immune-cell families.
Age-related immune dysfunction
Changes associated with aging that impair immune performance. It names a broad set of possible problems, rather than one uniform cell state or single measurement.
Recovery bands
Predefined ranges that measurements must return to for recovery to count as achieved. The gap detail requires such ranges between cycles but supplies neither the measurements nor their boundaries.
Clock misalignment
A mismatch involving the body's daily timing rhythms and the timing of activities or exposures. The gap detail mentions models of this process without supplying their findings.
What the question takes for granted
Premise could not be checked
persistence is governed by a that exposure order could cross.

An immune-cell is a family of cells sharing a particular recognition identity, and the question concerns families associated with unfamiliar threats. The named mathematical model describes interacting populations, with an invasion threshold representing a boundary at which a rare population can begin to establish itself. Treating that boundary as applicable would allow a change in exposure order to be interpreted as a switch in persistence rather than merely a change in response size.

S1 reports a model of competition among multiple T-cell families sharing stimuli, and S4 mentions analogies between immune-network equations and Lotka–Volterra equations. Neither establishes the proposed threshold for persistence. The supplied source set is too indirect to determine whether that threshold framing is valid in the system being asked about; it neither establishes nor refutes it.S1S4

The same question asked without the part nothing read establishes:

  • Does changing exposure order alter persistence of immune-cell families targeting unfamiliar threats when total , sleep loss, and nutrient availability are identical?
  • Under those matched conditions, are exposure-order differences in recognition of unfamiliar threats temporary or persistent?
What turns on the answer
  • Order switches persistence Under the proposed mechanism, changing the sequence would move an immune-cell family from conditions allowing establishment to conditions preventing it, or the reverse. Equal total exposures and resources would then be insufficient to establish equal preservation of recognition abilities. Such an outcome would still not, by itself, establish irreversible loss or recovery over ten years.
  • Order changes responses temporarily Sequence could change the size or distribution of immune responses while the affected families remain capable of recovering. A short-term reduction would then be insufficient evidence of permanent loss of recognition. The stated recovery requirement would turn on whether responses return to the predefined ranges between cycles.
  • Order does not change persistence With the specified totals and resources matched, the compared sequences would leave persistence unchanged. Exposure order would then not explain a persistence difference under those conditions. This outcome would not establish that overall immune function had recovered or remained stable for ten years.
Why it matters

If exposure sequence changes whether an immune-cell family persists, equal total exposures could leave different abilities to recognize unfamiliar threats. If an apparent loss instead reflects a temporary redistribution, an early measurement could mistake recoverable change for permanent loss. Conversely, a short-lived recovery in overall response could fail to establish that every affected recognition ability has returned. The distinction therefore affects whether the stated requirement for repeated recovery over ten years has actually been met; the supplied sources do not establish that chain of outcomes.

What is already established

RL-1 competition and models suggest mechanisms; RL-2 exposure monitoring records timing but establishes neither nor durable recovery.

What would have to be true

Coverage must return to between cycles, without cumulative or progressively longer recovery over ten years.

What is missing

No calibrated threshold distinguishes temporary allocation changes from irreversible under combined ordinary-life .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Exposure order changes which unfamiliar encounter antagonistic familiar during their . Familiar can productively stimulate recall receptors while delivering nonproductive or inhibitory signals through different, unfamiliar receptors. Residual familiar therefore creates in . Unfamiliar-first exposure permits before appear; familiar-first exposure prevents some from completing activation and establishing durable descendants. The apparent is consequently a rather than a . Reducing would stabilize .

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

Import: in an abstract . Let Ω be a bounded, experimentally sampled space of , and x a receptor's coordinates derived from an independent . For familiar j, approximate its by E_j = {x: r_j,inner < ||x − c_j|| ≤ r_j,outer}; c_j is its , r_j,inner bounds productive recognition, and r_j,outer bounds detectable . These must be validated rather than assumed. If F(t) is the set of familiar above their measured at time t, the excluded fraction is φ(t) = μ[Ω ∩ union_{j in F(t)} E_j]/μ(Ω), where μ measures recognition-space volume. Overlap is calculated by , so overlapping do not count twice. For i at x_i, H_i = integral over W_i of 1{x_i belongs to union_{j in F(t)} E_j} dt measures exposure during its W_i. An independently calibrated H_i threshold predicts establishment failure. Every geometric quantity concerns ; none represents tissue architecture, cell packing or .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

With unfamiliar , and , familiar variants that retain equivalent recall stimulation but move outside the unfamiliar 's independently mapped will abolish the order-dependent persistence deficit. Increasing nutrients or preventing recall-cell will not abolish that deficit. of the on standardized should reproduce the effect without . Failure of independently mapped to predict susceptible would reject the geometric model.

Would tell it apart from at least one rival. The text specifies observable disappearance, persistence, and reproduction of an effect under stated conditions, plus an explicit rejection condition. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, and can distinguish , and . Standardized is essential to exclude altered as the explanation. Testing durable establishment requires primary unfamiliar cells followed through and .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

With unfamiliar , and , familiar variants that retain equivalent recall stimulation but move outside the unfamiliar 's independently mapped will abolish the order-dependent persistence deficit. Increasing nutrients or preventing recall-cell will not abolish that deficit. of the on standardized should reproduce the effect without . Failure of independently mapped to predict susceptible would reject the geometric model.

  • What would separate them

    Borrowed familiar targets make recall immune cells kill unrelated new immune cells predicts: In with matched totals, hormonal schedules, nutrients and recall-cell abundance, unfamiliar cells displaying acquired familiar will undergo recall-cell-contact-associated . Selectively blocking recognition of the acquired familiar complex on unfamiliar cells will restore their and without increasing maintenance support. The effect should remain when unfamiliar show no to familiar . Absence of acquired-complex-dependent killing, together with successful through another rival's intervention, would reject this explanation.

  • What would separate them

    Exposure order can cause chance loss of unfamiliar immune cells despite favorable average growth predicts: Across many with the same unfamiliar , sequence and environmental schedule, persistence will vary probabilistically despite a positive . Increasing the initial number of otherwise identical unfamiliar will sharply reduce complete loss while leaving measured , recall abundance and recognition unchanged. Under an , P_loss(n,T) = q(T)^n, where n is initial number and q(T) is one 's probability of leaving no viable descendants at T. A nearly receptor-specific loss that remains after -number increases would favor the or targeted-killing rivals.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteA paper already fetched for this hypothesis bears on it

What it would take to refute it. 6 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: T cell decision-making decodes the dynamic antigenic landscape.; Cellular Immunotherapy for Cervical Cancer: Next Therapeutics Frontiers.; Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire..

6 papers retrieved around this hypothesis
  • Machine Learning for TCR Repertoire Epitope Annotation and Pattern Discovery.PMID 42473046 · full_text · 105,686 characters stored
  • Cancer Immune Responsiveness and MHC Class I Antigen Presentation: Mechanisms of Immune Escape and Immunotherapy Resistance in Gastrointestinal Cancers.PMID 42738808 · full_text · 101,695 characters stored
  • T cell decision-making decodes the dynamic antigenic landscape.PMID 42305540 · full_text · 58,373 characters stored
  • Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.PMID 42385225 · full_text · 77,444 characters stored
  • Cellular Immunotherapy for Cervical Cancer: Next Therapeutics Frontiers.PMID 42630674 · full_text · 134,298 characters stored
  • The heterogeneous and dynamic immune-tumor interface in breast cancer.PMID 42630908 · full_text · 52,332 characters stored

0 citation handles extracted; 1 Europe PMC search run; 7 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.